Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to investigate metabolic changes and maintaining efficacy
in stabilized patients with bipolar disorders who have pharmacologically induced weight gain.